Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocklatan vs Latanoprost on Episcleral Venous Blood Flow in Glaucoma Suspects
NCT04401982Phase 4Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 4 trial of netarsudil in ocular hypertension, glaucoma suspect, sponsored by University of Maryland, Baltimore. Started Jul 2026; status: recruiting.
02
Drugs
netarsudil
03
Conditions
ocular hypertensionglaucoma suspect
Beyond the preview
Go deeper on NCT04401982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401982.